Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
暂无分享,去创建一个
Chul Kim | R. Doebele | J. Smaill | A. Le | V. Tirunagaru | Stephen V. Liu | Andrea E. Doak | A. Patterson | Shevan Silva | M. Bull | A. Estrada-Bernal | Matthew R. Bull